Recombinant Human TNFRSF6 Protein，His

TNFRSF6, also known as Tumor Necrosis Factor Receptor Superfamily Member 6 or CD95, is a crucial protein involved in immune regulation and apoptosis. Its primary role is to mediate programmed cell death in response to various stimuli, which is essential for maintaining cellular homeostasis and immune system function. Dysregulation of TNFRSF6 has been implicated in numerous diseases, including autoimmune disorders, cancer, and neurodegenerative conditions. Research on recombinant TNFRSF6 proteins has garnered significant attention due to their potential therapeutic applications. By utilizing recombinant DNA technology, scientists can produce large quantities of the TNFRSF6 protein to study its structure-function relationships, signaling pathways, and interactions with ligands such as Fas ligand (FasL). Furthermore, these recombinant proteins can be explored as potential treatment modalities for diseases characterized by excessive cell proliferation or insufficient apoptosis. In cancer therapy, for instance, enhancing the apoptotic signaling through TNFRSF6 may improve the efficacy of existing treatments. Moreover, studying TNFRSF6 in the context of autoimmune diseases could reveal innovative strategies for modulation of immune responses. Thus, the investigation of TNFRSF6 recombinant proteins not only advances our understanding of fundamental biological processes but also holds promise for developing novel therapeutic interventions across various medical fields.